Sight Sciences, Inc. stock is up 63.64% since 30 days ago. The next earnings date is Mar 11, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 December’s closed higher than November. 0% of analysts rate it a buy.
Sight Sciences, Inc. engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. Its products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients. The company was incorporated in 2010 and is headquartered in Menlo Park, California.